Live Threat Map
According to a GlobalData survey, 39% of healthcare industry professionals globally expect to see a decrease in the amount that is being invested in emerging technologies over the next 12 months due to current economic conditions.
The survey, which was published in the leading data and analytics company’s latest report, ‘Digital Transformation and Emerging Technology in the Healthcare Industry – 2022 Edition’, reveals that 24% of surveyed healthcare industry stakeholders believed that there would be a minor decrease in investment in emerging technologies during the next 12 months, while 15% of them are prepared to see a moderate to significant decrease in investment, all due to the gloomy economic conditions.
Elton Kwok, Market Research Manager in Pharma at GlobalData, comments: “While COVID-19 may have forced businesses to implement emerging technologies to ensure business continuity during the pandemic, increasing inflation may discourage or even set back investment in the technologies. With ongoing financial disruptions, it is not surprising to see healthcare industry professionals being more reserved regarding near-future investments in digitalization.
“On the other hand, the survey found that one-third of respondents saw that inflation may have no impact on investment. Despite financial constraints, halting investments in emerging technologies and slowing down progress on digital transformation is not a strategy that all companies in the industry want to adopt.”
Read the full article here